Homocysteine, B-vitamins and CVD
- PMID: 18412997
- DOI: 10.1017/S0029665108007076
Homocysteine, B-vitamins and CVD
Abstract
There is considerable interest in plasma homocysteine (tHcy) as a CVD risk factor. Although the secondary prevention trials published to date have been inconclusive in confirming a benefit of tHcy-lowering treatment with B-vitamins on CVD events generally, such studies are widely recognised to have been insufficiently powered to detect a significant effect for the predicted magnitude of association between tHcy and heart disease risk, and therefore cannot be interpreted as evidence that no relationship exists. In fact, a recent meta-analysis of clinical trials has confirmed that folic acid supplementation reduces the risk of stroke, particularly in individuals without a history of stroke. Evidence supporting a causal relationship between elevated tHcy and heart disease also comes from genetic studies. The most important genetic determinant of tHcy in the general population is the common C677T variant in methylenetetrahydrofolate reductase (MTHFR) that results in higher tHcy. Individuals with the homozygous mutant (TT) genotype have a significantly higher (14-21%) risk of heart disease. Plasma tHcy is very responsive to intervention with the B-vitamins required for its metabolism, in particular folic acid, and to a lesser extent vitamins B12 and B6. Thus, although primarily aimed at reducing neural-tube defects, folic acid fortification may have an important role in the primary prevention of CVD via tHcy lowering. Besides folate, riboflavin is required as a cofactor for MTHFR and enhanced riboflavin status results in a marked lowering in tHcy specifically in individuals with the TT genotype, presumably by neutralising the variant form of the enzyme. About 10% of the UK and Irish populations have the TT genotype. In the present paper the potential role of folate and related B-vitamins in the primary prevention of CVD and the implications for nutrition policy are explored.
Similar articles
-
C(1) metabolism and CVD outcomes in older adults.Proc Nutr Soc. 2012 May;71(2):213-21. doi: 10.1017/S0029665111003387. Epub 2011 Dec 12. Proc Nutr Soc. 2012. PMID: 22152927 Review.
-
Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.Thromb Res. 2006;117(5):501-6. doi: 10.1016/j.thromres.2005.04.009. Epub 2005 Jun 1. Thromb Res. 2006. PMID: 15935452
-
Physiologic changes in homocysteine metabolism in pregnancy: a longitudinal study in Spain.Nutrition. 2011 Sep;27(9):925-30. doi: 10.1016/j.nut.2010.10.017. Epub 2011 Mar 2. Nutrition. 2011. PMID: 21367581
-
Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.J Heart Lung Transplant. 2004 Apr;23(4):405-12. doi: 10.1016/S1053-2498(03)00202-X. J Heart Lung Transplant. 2004. PMID: 15063399 Clinical Trial.
-
Postgraduate Symposium: The MTHFR C677T polymorphism, B-vitamins and blood pressure.Proc Nutr Soc. 2010 Feb;69(1):156-65. doi: 10.1017/S0029665109991728. Epub 2009 Dec 3. Proc Nutr Soc. 2010. PMID: 19954568 Review.
Cited by
-
Recent Updates on Epigenetic-Based Pharmacotherapy for Atherosclerosis.Diabetes Metab Syndr Obes. 2024 Apr 29;17:1867-1878. doi: 10.2147/DMSO.S463221. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38706808 Free PMC article. Review.
-
Identification of diagnostic biomarkers and immune cell infiltration in coronary artery disease by machine learning, nomogram, and molecular docking.Front Immunol. 2024 Apr 2;15:1368904. doi: 10.3389/fimmu.2024.1368904. eCollection 2024. Front Immunol. 2024. PMID: 38629070 Free PMC article.
-
Cognitive Impairment Is Associated with AMPAR Glutamatergic Dysfunction in a Mouse Model of Neuronal Methionine Synthase Deficiency.Cells. 2023 Apr 27;12(9):1267. doi: 10.3390/cells12091267. Cells. 2023. PMID: 37174668 Free PMC article.
-
Multivitamin/mineral supplementation and the risk of cardiovascular disease: a large prospective study using UK Biobank data.Eur J Nutr. 2022 Sep;61(6):2909-2917. doi: 10.1007/s00394-022-02865-4. Epub 2022 Mar 18. Eur J Nutr. 2022. PMID: 35301588
-
Homocysteine-Lowering Interventions in Chronic Kidney Disease.J Res Pharm Pract. 2021 Dec 25;10(3):114-124. doi: 10.4103/jrpp.jrpp_75_21. eCollection 2021 Jul-Sep. J Res Pharm Pract. 2021. PMID: 35198504 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical